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Abstract 
Patients with Personality Disorders (PDs) represent a particular burden for the health system and 
the clinicians attempting to treat them. The current commentary complements reviews of 
outcome studies on treatments for PD by focusing on the clinical utility, as defined by the 
American Psychological Association. As such, extending that notion, clinical utility of a 
treatment comprises aspects of implementation and training in the model, as well as qualities of 
the therapeutic technique and relationship. Our review suggests that a certain caution needs to be 
applied when reading outcome studies, based on specific methodological caveats. In specific 
contexts, inpatient and day hospital treatments have some initial appeal in reducing symptoms, in 
particular for the treatment of more severe forms of Cluster A and B PDs. Generally treatments 
for PDs are long-term treatments, administered in rather high dosage, which tends to be true 
irrespective of the treatment model. For specific treatment targets, there is emerging evidence on 
effectiveness of short-term interventions. The therapeutic relationship with patients with PDs 
may be characterized by strains and interactional difficulties which may be addressed using 
clinically adapted treatment strategies. In order to be effective, therapists should have an open-
minded and flexible approach to therapy, which is particularly central from an integrative 
perspective. Finally, we state that a key element for implementation of an effective treatment 
model is a manual-based training, albeit controversial, it remains a key component allowing for 
the trainee therapist to self-monitor his/her progress and get specific help in supervision as part 
of the learning process. We advocate that clinicians and administrators should consider these 
points as being specifically related with clinical utility of treatments for PDs, as they contribute 
to optimize the implementation process of a therapy approach to a specific context. 
Key-Words: Personality Disorders; Effectiveness; Clinical Utility; Psychotherapy 
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Psychotherapy of Personality Disorders: Questions of Clinical Utility 
Introduction 
 Clinicians tend to find the therapeutic work with patients presenting with Personality 
Disorders (PDs) challenging and, for some, unrewarding (Lewis & Appleby, 1988; Paris, 2007). 
Patients with PDs are known to present with a number of interaction and regulation problems 
(Bender & Skodol, 2007; Gunderson & Links, 2008; Gunderson & Lyons-Ruth, 2008; Paris, 
2007) which may provoke in therapists, among others, negative reactions, emotional retreat or 
feelings of helplessness (Lewis & Appleby, 1988). Personality disorders are also associated with 
a high societal burden of disease (Soeteman, Verheul, & Busschbach, 2008), along with 
individual suffering in terms of diminished quality of life on part of the patients, their families, 
and sometimes their clinicians. As such, despite accumulating outcome research (Budge, Moore, 
Del Re, Wampold, Baardseth & Nienhaus, 2013), some therapists in regular practice may 
continue to deliver sub-optimal treatments for patients with PDs. It is therefore necessary to 
bridge the gap between the results from outcome research, i.e., randomized controlled trials and 
meta-analyses, on the one hand and current clinical practice on the other. What is the actual 
clinical utility of different kinds of psychotherapy of PDs?  
In the present paper, we will address this question in a synthetic fashion, for clinicians 
and administrators interested in implementing concrete treatment programs in their communities. 
Answering this question might be particularly important from a psychotherapy integration 
perspective (Clarkin, Cain & Livesley, 2015; Dimaggio, 2015; Livesley, Dimaggio, & Clarkin, 
2016; Paris, 2015). In doing so, we will elaborate on specific questions related to clinical utility, 
implementation and optimal dosage of treatment (American Psychological Association, 2002). 
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Clinical utility of a treatment was defined by APA (2002, p. 1052) as “applicability, feasibility, 
and usefulness of the intervention in the local or specific setting where it is to be offered.” 
Beyond this general definition, clinical utility also includes questions of dosage, generalizability 
of a treatment whose efficacy has been demonstrated, cost-effectiveness and ease of 
implementation. It is also important to consider the ethical aspects of new psychotherapeutic 
treatments: liability and risk management are central in this regard. We aim to address three 
potential problems when implementing a therapy approach for patients with PDs, as non-
exhaustive examples of questions related to clinical utility of psychological treatments. 1) Is the 
methodological basis of the initial studies sound? 2) Which specificities of the context of 
implementation are there, requiring adaptations of outpatient treatment to partial hospitalization, 
inpatient treatment, or short-term intervention? 3) Which are active ingredients in treatments for 
PDs, in particular from an integrative perspective? If these problems are addressed, clinical 
utility of a specific treatment should be optimized in a specific context. Our reflections aims at a 
general statement for all PDs; however, it might be ideal to formulate these problems and 
implications for each PD category separately, given their high heterogeneity. 
Methodological basis of outcome studies for PDs 
The question outcome has been addressed by six meta-analyses focusing on 
psychological treatments, so far, out of which three focused on PDs in general (Budge et al., 
2013; Leichsenring & Leibing, 2003; Perry et al., 1999) and three on Borderline Personality 
Disorder (BPD) in particular (e.g., Binks et al., 2006; Stoffers et al., 2012); a number of 
treatment recommendations were also published (e.g., APA, 2001; Gaebel & Falkai, 2009; 
Hadjipavlou & Ogrodnickzuk, 2010; Leichsenring & Rabung, 2011; Sanislow & McGlashan, 
1998; Verheul & Herbrink, 2007).  
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 Whereas 20 years ago, there were hardly any researched treatment models specifically 
adapted to the treatment of PDs, leaving the clinician alone with this challenging group of 
patients, today, we are in the position of recommending the use of a number of treatment models 
which have shown effectiveness in the treatment of PDs.  
The first question we would like answer relates to absolute efficacy of treatments for 
which a number of studies exist, in particular for Borderline Personality Disorder, there is some 
evidence for Narcissistic and Dependent Personality Disorders, as well. In the most recent meta-
analysis, Budge and colleagues (2013) have compiled and analyzed 30 studies which compared 
an active psychotherapeutic treatment with treatment as usual. All these studies were published 
in the last 24 years; as such, it represents the most comprehensive review to date. They have 
shown that active psychotherapeutic treatments are more efficient than a minimal treatment as 
usual, with medium effect size (d = .40). Treatment as usual is defined here as minimal 
intervention strategies - not psychotherapy, but any form of psychiatric standard care. We note 
that those structured – bona fide – psychotherapy models present with at least six generic 
characteristics which may – or may not – contribute to their effectiveness: (a) a clear rationale or 
underlying theory of functioning of a patient presenting with PD, (b) a clear rationale for 
implementing structured treatment or predictions related to which therapeutic actions would 
foster symptom alleviation, (c) specific therapeutic procedures and techniques to be 
implemented, (d) specific, for most part manual-based, training modules for interested therapists 
to learn the model, (e) a particularly active therapist stance, (f) a particular focus on the building 
of the therapeutic relationship.  
 Among the ones most often studied, one can find the efficacious treatments for BPD, 
which are Dialectical-Behavior Therapy (e.g., Bohus et al., 2004; Linehan et al., 1993; Linehan 
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et al., 2006; McMain et al., 2009; Pasieczny & Connor, 2011; Pistorello et al., 2012; Priebe et al., 
2012; Soler et al., 2009; Van den Bosch et al., 2002), Transference-Focused Psychotherapy 
(Clarkin et al., 2007; Doering et al., 2010; Giesen-Bloo et al., 2006), Mentalization-Based 
Treatment (Bateman & Fonagy, 1999, 2008), Schema-focused Therapy (Bamelis et al., 2014; 
Farrell et al., 2009; Giesen-Bloo et al., 2006; Jacob et al., 2010) and Systems Training for 
Emotional Predictability and Problem Solving (Blum et al., 2008). 
 In addition to these, there is a number of potentially effective treatments for PDs which 
are alternative options for clinicians, but with more limited empirical bases, such as cognitive 
(Cottraux et al., 2009; Davidson et al., 2009; Emmelkamp et al., 2006), psychodynamic 
(Hoglend et al., 2011; Svartberg et al., 2004), humanistic-experiential (Pos & Greenberg, 2012; 
Pos, 2014; Sachse et al., 2011), dynamic-deconstructive (Gregory et al., 2010) and  interpersonal 
(Benjamin, 1993; Dimaggio et al., 2007) psychotherapies. All represent specific adaptations to 
the requirements of patients with PD. Even if not all have presented with empirical evidence, it 
can be postulated that they represent potentially valid treatment options for PD, to various 
extents, when compared to a minimum standard care. Some of these treatment models have been 
tested under “real” practice conditions, using effectiveness or naturalistic designs or other means 
(e.g., by formulating minimal exclusion criteria maintaining natural variability of the included 
patients) increasing the external validity of the trial, which is an argument favoring their clinical 
utility for a specific clinical context. 
A particularly important question for clinical utility is the observation that certain 
outcome studies seem to demonstrate “superiority” of a particular treatment approach over 
another active treatment. Does this mean that certain treatments are most effective and should be 
chosen for implementation? We argue, with Budge and colleagues, that these between-condition 
CLINICAL UTILITY OF TREATMENTS FOR PERSONALITY DISORDERS                     8 
 
effects may be attributable to a number of methodological problems of the initial studies, 
including the researcher’s allegiance. Researcher's allegiance is well-described as one of the 
most influential effects on results in efficacy studies (Luborsky, Diguer, Seligman, Rosenthal, 
Krause, Johnson, Halperin, Bishop, Berman, & Schweizer, 1999) and denotes the preference of a 
research team who conducts a study for a specific treatment model (and thus a non-preference 
for the alternative treatment model). We may add that another characteristic of an outcome study 
is the quality of ratings of the main outcome variable: raters who are non-blind to the treatment 
condition (i.e., who know the condition a specific patient is in) tend to report higher between-
group effects when compared to blind raters unknowledgeable of the treatment condition. 
Finally, differences in therapist adherence - the degree to which therapists actually do what the 
manual prescribes (and hold back from doing what the manual prohibites) - may be another 
source for differences found between active treatments. For these reasons, there might here and 
there be an individual study which reports between-condition effects for two active treatments: 
these results should be interpreted with great caution. Similar comments may be true for studies 
on efficacy for mediation. In the domain of psychotherapy for PDs, Giesen-Bloo, van Dyck, 
Spinhoven, van Tilburg, Dirksen, van Asselt, Kremers, Nadort and Arntz (2006) have found 
differences in efficacy between two effective long-term treatments: transference-focused (TFP) 
and schema-focused psychotherapy, favoring the latter. With regard to this study, Yeomans 
(2007) highlighted possible problems with therapist adherence in the TFP condition, whereas 
Levy, Meehan and Yeomans (2012, p. 145) discussed one of the “most potent methodological 
choices that results in allegiance effects”: the pre-selection of therapists who differ in skillfulness 
favoring the condition preferred by the researchers. When taking into account all these possible 
influences and when adequately interpreting findings of the literature as a whole, one can 
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conclude, with some caution, that active and PD-specific treatments tend to be equally effective. 
It is important to note that not all treatments present evidence for all categories of PDs – in fact, 
to our knowledge, no treatment presents evidence for all DSM-5 PD categories –: this does not 
mean they are ineffective for specific understudied forms of PDs. Therefore, all PD-specific 
bona fide treatments merit to be implemented, when done by skillful therapists. Skillfulness may 
be assured by sufficiently intense training of the therapists, which involves for patients with PDs 
case supervision based on tape-reviewing of the actual patient-therapist interaction. Manuals 
which were developed may also facilitate the self-monitoring by the therapists themselves, 
complementing individual case supervision. 
Specificities related to context of implementation 
 In certain countries and contexts, partial hospitalization and inpatient treatments are 
favored. Should treatments for PDs be used in these contexts?  
Partial hospitalization, or day hospital treatment, involves structured day activities over a 
period of time during which the patient spends the evenings and nights elsewhere. A recent 
clinical review and recommendation (Verheul & Herbrink, 2007) suggests, taking the empirical 
literature together, that Cluster A (with some severe forms of Cluster B) PDs responds well to 
long-term day hospital treatment, whereas Cluster C and remaining (less severe forms of) Cluster 
B PDs benefit rather from short-term treatment frames. It is advised that partial hospitalization is 
optimally followed by an outpatient psychotherapy treatment program which helps to deepen and 
generalize the effects of the initial day hospital treatment (Verheul et al., 2007; Gunderson & 
Links, 2008). Inpatient treatment of PDs generally represents long-term psychodynamically-
informed milieu-based treatment involving 6 to 12 months of hospitalization. Such intervention 
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tends to be effective for any PDs (see the review by Verheul & Herbrink, 2007). Shorter, multi-
modal and specifically intense, treatment frames have also shown their effectiveness (e.g., 
Sollberger, Gremaud-Heitz, Riemenschneider, Agarwalla, Benecke, Schwald, Küchenhoff, 
Walter, & Dammann, 2014). Similar to the day-hospital option, it is generally advised to plan a 
follow-up outpatient psychotherapy program after an inpatient treatment for PDs.  
When implementing a specific treatment approach in a community, the question of 
dosage is central. For how long and how intense should the treatment be? Based on four 
outpatient studies at the time, the meta-analysis by Perry, Banon and Ianni (1999) estimated that 
25% of patients with PD recovered after 5 months of treatment, 50% after 15 months (equivalent 
to 90 sessions) and 75% after 26 months (encompassing over 200 therapy sessions). Such 
progression over time is slightly smaller than found in other patients, and as described in the 
seminal contribution by Howard, Kopta, Krause, Merton and Orlinsky (1986). The latter 
describes a negatively accelerated curve, when relating dosage to therapy outcome over time. It 
needs to be noted that without appropriate controls, dose-effect relationships may not be 
attributable to the specific treatment approach, but may be the result of a spontaneous remission. 
Leichsenring and Rabung (2011) have reported that the rate of recovery for PDs might differ 
between therapy approaches, with an optimum of around 100 sessions for psychodynamic 
psychotherapies for PD to be effective, which might be shorter for cognitive therapies, although 
it is not clear if the detailed quality of recovery is comparable between these treatment 
approaches. In addition, several authors recommend highly intense treatments, for example twice 
weekly outpatient psychotherapy (e.g., Yeomans, Clarkin, & Kernberg, 2002) or intense 
multimodal inpatient treatment (Gaebel & Falkai, 2009). So far, these considerations on dosage 
include quite different forms of therapy and do not specify the severity of patients at intake. 
CLINICAL UTILITY OF TREATMENTS FOR PERSONALITY DISORDERS                     11 
 
Recently, researchers have demonstrated for specific target symptom short-term changes across 
treatment models: first effects were observed after three to 6 months of treatment for patients 
with borderline personality disorder (Blum et al., 2008; Kramer, Kolly, Berthoud, Keller, Preisig, 
Caspar, Berger, de Roten, Marquet, & Despland, 2014; Palmer, Davidson, Tyrer, Gumley, Tata, 
Norrie, Murray & Seivewright, 2008; Stanley, Brodsky, Nelson, & Dulit, 2007). Therefore, more 
studies are necessary on treatment dosage to determine optimal levels of care for each PD. 
Effective ingredients: the therapist and the therapeutic relationship 
 While the specific technique matters very little, as shown by a number of psychotherapy 
studies (see Budge et al., 2013), research has suggested the relevance of the so-called common 
factors in psychotherapy (e.g., empathy, therapeutic alliance, group cohesiveness; Smith, Barrett, 
Benjamin, & Barber, 2006; Wampold, 2001). There are several caveats when treating patients 
with PD. Firstly, it needs to be noted that, maybe contrary to clinical intuition, the therapeutic 
alliance in treatments for patients with BPD tends to be only weakly related with the therapeutic 
outcome at the end of treatment, according a recent meta-analysis (Scala, Ellison, & Levy, 
2014). Secondly, the common factor concept does not specify concretely how the therapist 
should go about to facilitate such common processes in the therapy room (Stiles, 2013). Thirdly, 
it might be particularly difficult for a therapist facing a patient with PD to implement such 
common factors, related to the challenging moment-by-moment interpersonal and 
intrapsychological fluctuations of mental states observed in these patients (Levy, Beeney, 
Wasserman, & Clarkin, 2010).  
There are specific clinical procedures facilitating the increase of the quality of the 
collaboration which are adapted to the requirements of patients with PDs and take into account 
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the afore-mentioned problems (McMain, Boritz, & Leybman, 2015). For example for borderline 
personality disorder, it was shown that when the therapist is responsive to behavior-underlying 
motives, there is additional symptom alleviation in the initial sessions of therapy for BPD 
(Kramer, Flückiger, Kolly, Caspar, Marquet, Despland, & de Roten, 2014; Kramer, Kolly et al., 
2014). For Cluster B and C PDs, it was shown that a focus on the reparation of strains and 
ruptures in the therapeutic alliance was related with increased symptom alleviation in 
psychotherapy (Muran, Safran, Wallner Samstag, & Winston, 2005); such alliance ruptures were 
rated higher by patients presenting with features of impulsivity, dysregulation and lability 
(Tufekcioglu, Muran, Safran, & Winston, 2013), compared to patient without these 
characteristics. These results call for more sophisticated and complex conceptions of the 
therapeutic interaction and relationship, the collaboration, patient engagement and the 
therapeutic alliance in treatments for PDs. 
 The person of the therapist is, last but not least, central in the treatment with patients 
presenting with PDs. It is noteworthy that most trials that have studied treatments for PDs did not 
take into account the therapist variable, even though a large literature exists on the moderating 
effect of the therapist on outcome (Baldwin & Imel, 2013). From a clinical perspective, 
Fernandez-Alvarez, Clarkin, Salgueiro, & Critchfield (2006, p. 215) have summarized that the 
effective therapist facing a patient with PD should (a) be open-minded, flexible and creative in 
the treatment approach, (b) be comfortable with long-term treatments requiring emotionally 
intense relationships, (c) be tolerant of his/her own negative affects, (d) have patience and (e) 
have a specific training in the treatment of PDs. The therapist needs therefore specific skills to 
manage his/her own inner (i.e., counter-transferential) reactions to the interactions with these 
patients, in order to be able to intervene effectively (Livesley, Dimaggio, & Clarkin, 2016). We 
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believe, that this can be achieved, again, by thorough training in the clinical models and 
procedures. If training seems important, accurate research on if training has the expected impact 
of the quality of intervention facing patients with PDs is still lacking. Recently, Keuroghlian, 
Palmer, Choi-Kain, Borba, Links and Gunderson (2015) have published a report on a one-day 
introductory class into psychiatric treatment for patients with borderline personality disorder. 
Only after this brief exposure, the participants reported more hopefulness in the treatment of 
these patients and increased levels of trust in their therapeutic skills, in addition, their image of 
these patients have changed towards a more nuanced view of a person with low self-esteem in 
need of care. Definitely, more research is needed on the impact of training for the quality of 
intervention facing these patients, in particular longer training programs. 
Conclusions 
Clinical utility of a treatment refers to its implementation and generalizability to different 
contexts of care, including in our view questions of quality of training, quality of intervention, 
dosage and the adaptation to specific settings. Because outcome research tends to suggest that no 
specific model imposes itself as the most effective, clinical utility of the model to be 
implemented refers to dynamically changing contextual variables. The success of such a therapy, 
given these contextual variables, might therefore not necessarily depend on the specific 
underlying theory nor on the specific therapeutic techniques, but rather on the quality of the 
therapeutic relationship the therapists and patients succeed to develop on a moment-by-moment 
and session-by-session basis, along with therapist characteristics in effectively dealing with the 
typical interaction problems presented by these patients. Integrative practice, and training 
therein, may therefore focus on the use of therapist skills in elaborating treatment contracts 
(Yeomans et al., 2002),), identify problems in the actual therapeutic relationship and discuss and 
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amend them (Tufekcioglu et al., 2013), offer specific individualized interventions tailored to 
each patient (Kramer et al., 2014) and the use of short-term intervention modules that are readily 
implemented (for example Stanley et al., 2007). A remaining challenge is the formulation of 
specific caveats of treatments for all PD categories: it might pose different problems to 
implement a therapy form for avoidant PD or borderline PD, for example. 
When implementing a therapy approach in the community – a necessary stepping stone 
between state of the art outcome research and the actual clinical reality – it is necessary to take 
into account the clinical utility and its implications. Providing therapy training in a community 
context is not sufficient per se, we think it should be done a specific way, by closely monitoring 
the therapist adherence incorporating feed-back over time, along with a specific focus on 
therapist and relationship variables, as they unfold in the interaction with the patient. 
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